These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24164426)

  • 1. Metabonomic profiling revealed an alteration in purine nucleotide metabolism associated with cardiac hypertrophy in rats treated with thiazolidinediones.
    Liu Y; Yan X; Mao G; Fang L; Zhao B; Liu Y; Tang H; Wang N
    J Proteome Res; 2013 Dec; 12(12):5634-41. PubMed ID: 24164426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
    LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
    Sakai S; Miyauchi T; Irukayama-Tomobe Y; Ogata T; Goto K; Yamaguchi I
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():16S-20S. PubMed ID: 12193046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones up-regulate insulin-like growth factor-1 receptor via a peroxisome proliferator-activated receptor gamma-independent pathway.
    Higashi Y; Holder K; Delafontaine P
    J Biol Chem; 2010 Nov; 285(47):36361-8. PubMed ID: 20843793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the bovine genes of the de novo AMP synthesis pathway.
    Bønsdorff T; Gautier M; Farstad W; Rønningen K; Lingaas F; Olsaker I
    Anim Genet; 2004 Dec; 35(6):438-44. PubMed ID: 15566465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
    Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
    Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
    Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.
    Chang CS; Tsai PJ; Sung JM; Chen JY; Ho LC; Pandya K; Maeda N; Tsai YS
    Am J Pathol; 2014 Feb; 184(2):442-53. PubMed ID: 24287404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thiazolidinedione pioglitazone increases cholesterol biosynthetic gene expression in primary cortical neurons by a PPARgamma-independent mechanism.
    Cocks G; Wilde JI; Graham SJ; Bousgouni V; Virley D; Lovestone S; Richardson J
    J Alzheimers Dis; 2010; 19(2):631-46. PubMed ID: 20110608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo.
    Bogacka I; Xie H; Bray GA; Smith SR
    Diabetes Care; 2004 Jul; 27(7):1660-7. PubMed ID: 15220243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism.
    Gooding JR; Jensen MV; Dai X; Wenner BR; Lu D; Arumugam R; Ferdaoussi M; MacDonald PE; Newgard CB
    Cell Rep; 2015 Oct; 13(1):157-167. PubMed ID: 26411681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
    Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
    Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M; Balakumar P; Singh M
    Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and PPAR insulin sensitizers.
    Bhatia V; Viswanathan P
    Curr Opin Investig Drugs; 2006 Oct; 7(10):891-7. PubMed ID: 17086933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.